1. Home
  2. MAIN vs ADMA Comparison

MAIN vs ADMA Comparison

Compare MAIN & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIN
  • ADMA
  • Stock Information
  • Founded
  • MAIN 2007
  • ADMA 2004
  • Country
  • MAIN United States
  • ADMA United States
  • Employees
  • MAIN N/A
  • ADMA N/A
  • Industry
  • MAIN Finance/Investors Services
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MAIN Finance
  • ADMA Health Care
  • Exchange
  • MAIN Nasdaq
  • ADMA Nasdaq
  • Market Cap
  • MAIN 5.3B
  • ADMA 5.1B
  • IPO Year
  • MAIN 2007
  • ADMA N/A
  • Fundamental
  • Price
  • MAIN $65.09
  • ADMA $17.80
  • Analyst Decision
  • MAIN Hold
  • ADMA Strong Buy
  • Analyst Count
  • MAIN 4
  • ADMA 3
  • Target Price
  • MAIN $59.75
  • ADMA $27.67
  • AVG Volume (30 Days)
  • MAIN 501.1K
  • ADMA 3.3M
  • Earning Date
  • MAIN 08-07-2025
  • ADMA 08-06-2025
  • Dividend Yield
  • MAIN 6.54%
  • ADMA N/A
  • EPS Growth
  • MAIN 13.61
  • ADMA 469.09
  • EPS
  • MAIN 6.07
  • ADMA 0.85
  • Revenue
  • MAIN $558,286,000.00
  • ADMA $474,174,000.00
  • Revenue This Year
  • MAIN $3.83
  • ADMA $21.11
  • Revenue Next Year
  • MAIN $1.43
  • ADMA $25.97
  • P/E Ratio
  • MAIN $10.73
  • ADMA $20.93
  • Revenue Growth
  • MAIN 8.13
  • ADMA 43.58
  • 52 Week Low
  • MAIN $47.00
  • ADMA $13.50
  • 52 Week High
  • MAIN $67.77
  • ADMA $25.67
  • Technical
  • Relative Strength Index (RSI)
  • MAIN 53.00
  • ADMA 51.09
  • Support Level
  • MAIN $64.73
  • ADMA $16.93
  • Resistance Level
  • MAIN $67.77
  • ADMA $17.90
  • Average True Range (ATR)
  • MAIN 1.21
  • ADMA 0.86
  • MACD
  • MAIN -0.24
  • ADMA 0.04
  • Stochastic Oscillator
  • MAIN 44.74
  • ADMA 59.11

About MAIN Main Street Capital Corporation

Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancing, and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants, and other securities of the lower middle market and middle market companies based in the United States. Business functioned through the U.S. region and it derives the majority of its income from the source of fees, commission, and interest.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Share on Social Networks: